title: Human Prostate Cancer Cells Secrete Neuro-Protective Factors in Response to Cryotherapy.
abstract: Cryoablation is one of the established treatment modalities for prostate cancer management. Although, it is target specific, it may still lead to damage to the nerve fibers around the prostate tumor. In this study, by directly exposing the co-cultures of prostate cancer cells, PC-3 and Schwann cell-Dorsal Root Ganglion neuron (SC-DRG) to cryo-shock and by exposing SC-DRG to cryo-shock conditioned media (CSCM) obtained from PC-3 cells, robust neuro-protective effects were observed. Since this neuro-protective effect originated from cryotherapy-treated PC-3 cells, the presence of putative factors secreted by PC-3 cells in the medium following cryo-shock was analyzed. Using human cytokine antibody array analysis, differential release of cytokines in CSCM was observed with induced release of cytokines involved in neuro-protection like IL-1α, MIP-4, MIP-5, Leptin, IL-15 and ICAM-1 with simultaneous inhibition of TNFRI and TNFRII that are implicated in killing of nerve cells. Further, using Matrix Assisted Laser Desorption/Ionization-Time Of Flight (MALDI-TOF) sequencing, two proteins were identified namely, CypA (cyclophilin A) and NM23 (nonmetastatic protein 23) in the CSCM. CypA functions as a mediator of intracellular as well as extracellular neuro-protective mechanisms and NM23 has been implicated as a potential suppressor protein of tumor metastasis. Thus, this study revealed the presence of factors in CSCM that has the potential to protect normal neuronal cells and suppress metastasis.
authors.affiliation: Department of Radiation Oncology, University of Miami, Miami, Florida.
authors.forename: Seema
authors.initials: S
authors.lastname: Gupta
authors.forename: Mini
authors.initials: M
authors.lastname: Varghese
authors.forename: Mohammed M
authors.initials: MM
authors.lastname: Shareef
authors.forename: Mansoor M
authors.initials: MM
authors.lastname: Ahmed
references.citation: J Biol Chem. 2002 Jun 21;277(25):22959-65
references.pmid: 11943775
references.citation: Adv Exp Med Biol. 2000;479:277-88
references.pmid: 10897428
references.citation: Exp Cell Res. 2004 Dec 10;301(2):293-304
references.pmid: 15530864
references.citation: J Cell Biochem. 2006 Feb 15;97(3):501-11
references.pmid: 16187294
references.citation: J Neurochem. 2007 Mar;100(5):1407-20
references.pmid: 17241124
references.citation: World J Surg. 2005 Mar;29(3):276-80
references.pmid: 15706440
references.citation: Cancer Invest. 2003;21(5):720-8
references.pmid: 14628430
references.citation: J Neurochem. 2008 Dec;107(6):1741-52
references.pmid: 19014377
references.citation: J Neurosci. 2006 Jan 11;26(2):508-17
references.pmid: 16407548
references.citation: J Immunol. 2000 Feb 1;164(3):1488-97
references.pmid: 10640766
references.citation: Biochem J. 2006 Jul 15;397(2):247-59
references.pmid: 16792527
references.citation: Neurobiol Dis. 2007 Jan;25(1):54-64
references.pmid: 17011206
references.citation: Brain Res Bull. 2009 May 29;79(3-4):169-76
references.pmid: 19429187
references.citation: J Biol Chem. 1997 Mar 7;272(10):6677-84
references.pmid: 9045699
references.citation: Cell. 1993 Jun 18;73(6):1067-78
references.pmid: 8513493
references.citation: Cancer Lett. 1999 Oct 18;145(1-2):93-9
references.pmid: 10530775
references.citation: Int J Cancer. 2001 Aug 15;93(4):526-33
references.pmid: 11477556